List of Tables
Table 1. Global Nucleic Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nucleic Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nucleic Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nucleic Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nucleic Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nucleic Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nucleic Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nucleic Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nucleic Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nucleic Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nucleic Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Nucleic Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nucleic Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nucleic Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nucleic Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Nucleic Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Nucleic Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Nucleic Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Nucleic Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nucleic Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Nucleic Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nucleic Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Nucleic Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nucleic Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Nucleic Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Nucleic Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nucleic Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nucleic Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nucleic Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nucleic Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nucleic Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nucleic Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nucleic Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nucleic Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nucleic Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nucleic Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nucleic Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nucleic Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nucleic Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nucleic Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nucleic Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nucleic Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nucleic Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nucleic Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nucleic Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nucleic Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nucleic Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nucleic Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Nucleic Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Nucleic Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Nucleic Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Nucleic Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nucleic Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nucleic Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Nucleic Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Nucleic Vaccine Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nucleic Vaccine Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nucleic Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Nucleic Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Nucleic Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Nucleic Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Nucleic Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nucleic Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nucleic Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Nucleic Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Nucleic Vaccine Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nucleic Vaccine Price (US$/Unit) by Application (2026-2031)
Table 70. Moderna Company Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Moderna Nucleic Vaccine Product
Table 74. Moderna Recent Developments/Updates
Table 75. CureVac Company Information
Table 76. CureVac Description and Business Overview
Table 77. CureVac Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. CureVac Nucleic Vaccine Product
Table 79. CureVac Recent Developments/Updates
Table 80. Inovio Company Information
Table 81. Inovio Description and Business Overview
Table 82. Inovio Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Inovio Nucleic Vaccine Product
Table 84. Inovio Recent Developments/Updates
Table 85. Sanofi Company Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sanofi Nucleic Vaccine Product
Table 89. Sanofi Recent Developments/Updates
Table 90. GSK Company Information
Table 91. GSK Description and Business Overview
Table 92. GSK Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. GSK Nucleic Vaccine Product
Table 94. GSK Recent Developments/Updates
Table 95. CNBG Company Information
Table 96. CNBG Description and Business Overview
Table 97. CNBG Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. CNBG Nucleic Vaccine Product
Table 99. CNBG Recent Developments/Updates
Table 100. Hualan Bio Company Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Hualan Bio Nucleic Vaccine Product
Table 104. Hualan Bio Recent Developments/Updates
Table 105. Zhifei Shengwu Company Information
Table 106. Zhifei Shengwu Description and Business Overview
Table 107. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Zhifei Shengwu Nucleic Vaccine Product
Table 109. Zhifei Shengwu Recent Developments/Updates
Table 110. Liaoning Chengda Company Information
Table 111. Liaoning Chengda Description and Business Overview
Table 112. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Liaoning Chengda Nucleic Vaccine Product
Table 114. Liaoning Chengda Recent Developments/Updates
Table 115. BioKangtai Company Information
Table 116. BioKangtai Description and Business Overview
Table 117. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. BioKangtai Nucleic Vaccine Product
Table 119. BioKangtai Recent Developments/Updates
Table 120. CanSinoBIO Company Information
Table 121. CanSinoBIO Description and Business Overview
Table 122. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. CanSinoBIO Nucleic Vaccine Product
Table 124. CanSinoBIO Recent Developments/Updates
Table 125. Walvax Biotechnology Company Information
Table 126. Walvax Biotechnology Description and Business Overview
Table 127. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Walvax Biotechnology Nucleic Vaccine Product
Table 129. Walvax Biotechnology Recent Developments/Updates
Table 130. Fosun Pharma Company Information
Table 131. Fosun Pharma Description and Business Overview
Table 132. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Fosun Pharma Nucleic Vaccine Product
Table 134. Fosun Pharma Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Nucleic Vaccine Distributors List
Table 138. Nucleic Vaccine Customers List
Table 139. Nucleic Vaccine Market Trends
Table 140. Nucleic Vaccine Market Drivers
Table 141. Nucleic Vaccine Market Challenges
Table 142. Nucleic Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nucleic Vaccine
Figure 2. Global Nucleic Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nucleic Vaccine Market Share by Type: 2024 & 2031
Figure 4. Preventive Nucleic Vaccine Product Picture
Figure 5. Therapeutic Nucleic Vaccine Product Picture
Figure 6. Global Nucleic Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Nucleic Vaccine Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Nucleic Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Nucleic Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global Nucleic Vaccine Sales (2020-2031) & (K Units)
Figure 14. Global Nucleic Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 15. Nucleic Vaccine Report Years Considered
Figure 16. Nucleic Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Nucleic Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Nucleic Vaccine Players: Market Share by Revenue in Nucleic Vaccine in 2024
Figure 19. Nucleic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Nucleic Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Nucleic Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America Nucleic Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Nucleic Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe Nucleic Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Nucleic Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Nucleic Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Nucleic Vaccine Sales Market Share by Country (2020-2031)
Figure 45. Latin America Nucleic Vaccine Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Nucleic Vaccine Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Nucleic Vaccine Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Nucleic Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Nucleic Vaccine by Type (2020-2031)
Figure 55. Global Revenue Market Share of Nucleic Vaccine by Type (2020-2031)
Figure 56. Global Nucleic Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Nucleic Vaccine by Application (2020-2031)
Figure 58. Global Revenue Market Share of Nucleic Vaccine by Application (2020-2031)
Figure 59. Global Nucleic Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 60. Nucleic Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
